No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO
Express News | Cero Therapeutics, Inc. Appoints Chris Ehrlich CEO
Express News | Cero Therapeutics Holdings - Potential Offer and Sale of up to 210 Mln Shares by Keystone Capital Partners
10-Q/A: Quarterly report (Amendment)
10-Q: Q3 2024 Earnings Report
No Data